Discounted Cash Flow Rating

Buy

Return on Equity Rating

Neutral

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Certara, Inc. Common Stock (CERT)

Services-prepackaged Software

https://www.certara.com

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The group has a business presence in the United States, EMEA, and other regions, of which a majority of revenue is derived from the United States.

100 OVERLOOK CENTER, SUITE 101
PRINCETON, NJ

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/11/2020

Market Cap

1,945,952,455

Shares Outstanding

159,850,000

Weighted SO

159,844,780

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

NRC --.--%

NXGN --.--%

HCAT --.--%

HSTM --.--%

HSTM --.--%

PRVA --.--%

HQY --.--%

Beta

1.5260

Last Div

0.0000

Range

11.7-19.87

Chg

-0.0650

Avg Vol

676746

Mkt Cap

1945952455

Exch

NASDAQ

Country

US

Phone

609 716 7900

DCF Diff

2.6724

DCF

9.3976

Div Yield

0.0000

P/S

5.3526

EV Multiple

37.1938

P/FV

1.8606

Div Yield %

0.0000

P/E

-24.6741

PEG

-1.7266

Payout

0.0000

Current Ratio

2.6105

Quick Ratio

2.6494

Cash Ratio

1.7394

DSO

98.4362

DIO

-9.7924

Op Cycle

88.6439

DPO

9.3540

CCC

79.2899

Gross Margin

0.4847

Op Margin

-0.1634

Pretax Margin

-0.2302

Net Margin

-0.2164

Eff Tax Rate

0.0600

ROA

-0.0511

ROE

-0.0750

ROCE

-0.0421

NI/EBT

0.9400

EBT/EBIT

1.4086

EBIT/Rev

-0.1634

Debt Ratio

0.1958

D/E

0.2889

LT Debt/Cap

0.2196

Total Debt/Cap

0.2241

Int Coverage

-4.9737

CF/Debt

0.2284

Equity Multi

1.4756

Rec Turnover

3.7080

Pay Turnover

39.0208

Inv Turnover

-37.2740

FA Turnover

21.4714

Asset Turnover

0.2361

OCF/Share

0.4290

FCF/Share

0.3161

Cash/Share

1.4306

OCF/Sales

0.1894

FCF/OCF

0.7370

CF Coverage

0.2284

ST Coverage

8.9184

CapEx Coverage

3.8024

Div&CapEx Cov

3.8024

P/BV

1.8606

P/B

1.8606

P/S

5.3526

P/E

-24.6741

P/FCF

38.3492

P/OCF

28.1962

P/CF

28.1962

PEG

-1.7266

P/S

5.3526

EV Multiple

37.1938

P/FV

1.8606

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Dec 13, 16:30 Certara Acquires Applied BioMath Expanding Its Biosimulation Portfolio to Industrialize New Capabilities for Optimal Dosing for Novel Therapies GlobeNewswire Inc. Nov 21, 16:30 Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development  

Revenue Product Segmentation